No indication of progress in Orkambi negotiations

The Director General of the Health Service Executive says it is too early to say if new talks will see Orkambi provided for cystic fibrosis patients.

Negotiations resumed today after breaking down when the manufacturer, Vertex demanded nearly €160,000 per patient per year for the drug.